All-Trans Retinoic Acid (atRA) effectively improves liver steatosis in a rabbit model of high fat induced liver steatosis
Authors:
- 23 March 2020
- journal article
- research article
- Published by Taylor & Francis in Archives of Physiology and Biochemistry
- Vol. 128 (4) , 1010-1015
Abstract
The aim of this study is to evaluate the role of All-Trans Retinoic Acid, the biologically active metabolite of retinoids, on liver steatosis in a rabbit model of high fat induced lever steatosis. 30 male rabbits were evaluated in 5 groups: group 1 treated with normal diet, group 2–5 included rabbit’s groups 2 to 5 were fed on high cholesterol diet, group 2 received no drugs, group 3 received atorvastatin, group 4 received atRA, and group 5 received both the drugs. the liver was obtained for histopathological evaluation. oral administration of atRA, atorvastatin or their combination significantly decreased serum levels of total cholesterol, LDL, AST and ALT. atorvastatin slightly but atRA remarkably decreased liver steatosis where the difference was significant. atRA group showed the highest TAC and the lowest PCO concentrations. atRA can be effective in reducing liver steatosis and its antioxidant effect plays a crucial role in the process.Keywords
This publication has 26 references indexed in Scilit:
- All-trans-Retinoic Acid Ameliorates Hepatic Steatosis in Mice by a Novel Transcriptional CascadeHepatology, 2013
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adultsAlimentary Pharmacology & Therapeutics, 2011
- Meta‐analysis: antioxidant supplements for liver diseases – the Cochrane Hepato‐Biliary GroupAlimentary Pharmacology & Therapeutics, 2010
- Pioglitazone, Vitamin E, or Placebo for Nonalcoholic SteatohepatitisNew England Journal of Medicine, 2010
- Induction of Transglutaminase 2 by a Liver X Receptor/Retinoic Acid Receptor α Pathway Increases the Clearance of Apoptotic Cells by Human MacrophagesCirculation Research, 2009
- Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trialScandinavian Journal of Gastroenterology, 2009
- Orlistat for overweight subjects with nonalcoholic steatohepatitisHepatology, 2009
- Retinoic acid prevents Chlamydia pneumoniae-induced foam cell development in a mouse model of atherosclerosisMicrobes and Infection, 2008
- Retinoic Acid Promotes the Generation of Pancreatic Endocrine Progenitor Cells and Their Further Differentiation into β-CellsPLOS ONE, 2008
- Retinoic acid receptor α dominant negative form causes steatohepatitis and liver tumors in transgenic miceHepatology, 2004